In particular, subjects with serum IGF-I levels in the upper quartile of the normal range have been shown to be at increased risk of premenopausal breast cancer and other cancers, such as prostate, lung, colorectal, endometrial and bladder as compared to subjects who have values in the lower quartile [34, 59, 60, 62, 63]. Here, IGF1 is linked to cancer.